NAT2 slow acetylation and bladder cancer risk: A meta-analysis of 24 case-control studies.

被引：0
|
作者：
Marcus, PM [1 ]
Vineis, P [1 ]
Rothman, N [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 1999年 / 149卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
189
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [1] NAT2 slow acetylation and bladder cancer risk: a metaanalysis of 22 case-control studies conducted in the general population
    Marcus, PM
    Vineis, P
    Rothman, N
    PHARMACOGENETICS, 2000, 10 (02): : 115 - 122
  • [2] GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis
    Moore, L. E.
    Baris, D. R.
    Figueroa, J. D.
    Garcia-Closas, M.
    Karagas, M. R.
    Schwenn, M. R.
    Johnson, A. T.
    Lubin, J. H.
    Hein, D. W.
    Dagnall, C. L.
    Colt, J. S.
    Kida, M.
    Jones, M. A.
    Schned, A. R.
    Cherala, S. S.
    Chanock, S. J.
    Cantor, K. P.
    Silverman, D. T.
    Rothman, N.
    CARCINOGENESIS, 2011, 32 (02) : 182 - 189
  • [3] NAT2 slow acetylation and bladder cancer in workers exposed to benzidine
    Carreón, T
    Ruder, AM
    Schulte, PA
    Hayes, RB
    Rothman, N
    Waters, M
    Grant, DJ
    Boissy, R
    Bells, DA
    Kadlubar, FF
    Hemstreet, GP
    Yin, S
    Lemasters, GK
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 161 - 168
  • [4] NAT2 polymorphism and lung cancer risk: A meta-analysis
    Cui, Dan
    Wang, Zhanwei
    Zhao, Erjiang
    Ma, Jie
    Lu, Weiquan
    LUNG CANCER, 2011, 73 (02) : 153 - 157
  • [5] Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies
    Wan, Guo-Xing
    Chen, Ping
    Yu, Xiong-Jie
    Di, Quan-Shu
    Yu, Yuan-Dong
    Lei, Jin-Hua
    Tai, Yun-Yan
    Cao, Feng-Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 3935 - 3945
  • [6] John Cunningham virus infection and the risk of colorectal cancer: A meta-analysis of case-control studies.
    Kimla, Lenka J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer:: results from the Spanish Bladder Cancer Study and meta-analyses
    García-Closas, M
    Malats, N
    Silverman, D
    Dosemeci, M
    Kogevinas, M
    Hein, DW
    Tardón, A
    Serra, C
    Carrato, A
    García-Closas, R
    Lloreta, J
    Castaño-Vinyals, G
    Yeager, M
    Welch, R
    Chanock, S
    Chatterjee, N
    Wacholder, S
    Samanic, C
    Torà, M
    Fernández, F
    Real, FX
    Rothman, N
    LANCET, 2005, 366 (9486): : 649 - 659
  • [8] NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish bladder cancer study and meta-analyses
    Zlotta, AR
    EUROPEAN UROLOGY, 2006, 49 (02) : 412 - 412
  • [9] GSTM1 and NAT2 Polymorphisms and Colon, Lung and Bladder Cancer Risk: A Case-control Study
    Zupa, Angela
    Sgambato, Alessandro
    Bianchino, Gabriella
    Improta, Giuseppina
    Grieco, Vitina
    La Torre, Giuseppe
    Campisi, Biagina
    Traficante, Antonio
    Aieta, Michele
    Cittadini, Achille
    ANTICANCER RESEARCH, 2009, 29 (05) : 1709 - 1714
  • [10] Association of Slow Acetylation Profile of NAT2 with Breast and Gastric Cancer Risk in Brazil
    Fernandes, Marianne Rodrigues
    De Carvalho, Darlen Cardoso
    Campos Ribeiro Dos Santos, Andrea Kelly
    Batista Dos Santos, Sidney Emanuel
    De Assumpcao, Paulo Pimentel
    Rodriguez Burbano, Rommel Mario
    Carneiro Dos Santos, Ney Pereira
    ANTICANCER RESEARCH, 2013, 33 (09) : 3683 - 3689
12345